Article

BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression

2022-08-01

Abstract excerpt

<title>Abstract</title> <p>Bromodomain and extra-terminal tail (BET) proteins have been identified as potential epigenetic targets in cancer, including glioblastoma. These epigenetic modifiers link the histone code to gene transcription that can be disrupted with small molecule BET inhibitors (BETi). With the aim of developing rational combination treatments for glioblastoma, we analyzed BETi-induced differential...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 596c7d93-3c47-5089-b8ef-55e8c1ca89cf
DOI: 10.21203/rs.3.rs-1832996/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expressionDOI 10.21203/rs.3.rs-1832996/v1Read

BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expressionSemantic proximity Read

BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cellsSemantic proximity Read

CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma linesSemantic proximity Read

Bromodomain and Extraterminal Domain (BET) Protein Inhibition Hinders Glioblastoma Progression by Inducing Autophagy-Dependent DifferentiationSemantic proximity Read

Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System TumorsSemantic proximity Read

Targeting BET Bromodomains in CancerSemantic proximity Read

Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genesSemantic proximity Read

R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition.Semantic proximity Read

The novel BET inhibitor UM-002 reduces glioblastoma cell proliferation and invasionSemantic proximity Read

Epigenetic dysregulation ofTET2in human glioblastomaSemantic proximity Read

Epigenetic Targeting of GlioblastomaSemantic proximity Read

Investigational BET bromodomain protein inhibitors in early stage clinical trials for acute myelogenous leukemia (AML)Semantic proximity Read